Low-dose radiotherapy versus corticosteroid injection for hand and wrist osteoarthritis

Low-Dose Radiotherapy Compared to Corticosteroid Injection for Treatment of Hand Osteoarthritis

Phase 4 Interventional Mayo Clinic · NCT07217405

This trial will test whether low-dose radiotherapy or a corticosteroid injection works better to reduce pain for people 50 and older with hand or wrist osteoarthritis.

Quick facts

PhasePhase 4
Study typeInterventional
Enrollment165 (estimated)
Ages50 Years and up
SexAll
SponsorMayo Clinic Academic / other
Locations1 site (Rochester, Minnesota)
Trial IDNCT07217405 on ClinicalTrials.gov

What this trial studies

This interventional, phase 4 trial at Mayo Clinic in Rochester compares two active treatments for hand/wrist osteoarthritis: low-dose radiotherapy and corticosteroid joint injection. Eligible participants are adults 50 years or older with radiographic osteoarthritis (Kellgren-Lawrence grade 2–4) and at least moderate hand pain (VAS ≥40). Participants receive one of the two treatments and complete standardized pain and function questionnaires during follow-up visits. The trial excludes patients with inflammatory arthritis, recent hand surgery or injections, opioid or recent steroid use, and other confounding hand conditions.

Who should consider this trial

Good fit: Adults aged 50 or older with radiographic hand or wrist osteoarthritis (Kellgren-Lawrence grade 2–4), a current hand pain score of at least 40/100 on VAS, and ability to complete study questionnaires are ideal candidates.

Not a fit: People with inflammatory joint disease, recent hand surgery or injection, recent opioid or systemic steroid use, fibromyalgia/central sensitization, or other confounding hand conditions are excluded and unlikely to benefit from this trial.

Why it matters

Potential benefit: If successful, the comparison could identify a treatment that provides more durable pain relief or better function for people with hand or wrist osteoarthritis.

How similar studies have performed: Corticosteroid injections are commonly used and provide short-term pain relief, while low-dose radiotherapy has shown symptomatic benefit in some smaller European studies but is less widely studied for hand osteoarthritis.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient at Mayo Clinic, Rochester, MN
* Age 50 years or older
* Mild, moderate, or severe hand OA (Kellgren and Lawrence classification grade 2, 3, or 4) on hand radiographs within the last 24 months
* Hand OA pain with a minimum VAS score relating to hand pain of ≥40 (on a 100-point scale) when using the affected hand
* Ability to complete study questionnaires

Exclusion Criteria:

* History of previous surgery to the affected hand(s)
* Autoimmune joint disease such as rheumatoid arthritis or psoriatic arthritis
* Active confounding hand condition such as stenosing tenosynovitis or Dupuytren's contracture
* Recent injury (within last 1 month) to the affected hand causing current pain
* History of crystalline arthritis (gout or pseudogout) flare in the affected hand(s)
* Active use of opioid pain medication(s) or oral steroids within the last 3 months
* Fibromyalgia or central sensitization syndrome
* Hand CSI or other hand injection within the past 3 months
* History of hand LDRT within the past 3 months
* Poorly controlled diabetes (HbA1c \> 10%)
* Active infection
* Current pregnancy

Where this trial is running

Rochester, Minnesota

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Osteoarthritis HandOsteoarthritis Wrist
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.